One-step separation-free amperometric biosensor for the detection of protein

A novel enzyme biosensor for the detection of protein is presented. The biosensor was made from a screen-printed three-electrode configuration. Amino acid oxidase was immobilized with glutaraldehyde and polyethylenimine on a working electrode made of rodinised carbon. A protease was immobilized on an immunodyne membrane and was placed on the electrode. A protein sample was deposited on the membrane, and was subsequently hydrolyzed to amino acids in the presence of the protease. This in turn produced hydrogen peroxide by the immobilized amino acid oxidase. The oxidation of hydrogen peroxide was then detected at +400 mV vs. an Ag/AgCl reference electrode. The method was very effective at detecting a very low level of protein. The sensor does not require any washing step. The sensor works with only 40 μl of sample per detection, and may be used on-site as a disposable sensor using a hand-held meter. The electrodes are also stable for more than 6 weeks.     

Fabrication of Large‐Scale Hierarchical ZnO Hollow Spheroids for Hydrophobicity and Photocatalysis

We report here the preparation of a crystalline, pure hexagonal phase of ZnO as hollow 500–800 nm spheroids in the presence of organic bases, such as pyridine, using zinc acetate as the precursor salt. The spheroids exhibit unique 3D hierarchical architectures, like cocoons, and demonstrate improved superhydrophobic (water contact angle, 150°) character due to the inherited air‐trapped capillarity within the cocoon structure. The simple synthetic strategy used in this process is modified hydrothermolysis (MHT), which represents a general approach and may contribute to the formation mechanism of the hollow nanostructures with highly improved porosity. Depending on the concentration of the precursor salt, it has been possible to cover glass plates or the inner wall of a reaction vessel with ZnO nanocrystals. A low salt concentration (<0.01 M ) allows the easy preparation of a superhydrophobic glass surface, whereas a high salt concentration (>0.01 M ) results in the precipitation of cocoons at the bottom of the reaction vessel as a solid mass together with a deposited thin film of ZnO nanocrystals covering the inner wall of the glass vessel. The thickness of the film successively grows through repetitive hydrothermolysis processes for which a low salt concentration (<0.01 M ) was employed. Because of the hollow cocoonlike morphology, the surface area of the film is greatly increased, which makes it accessible for functionalization by incoming substrates from both sides (internally and externally) and helps to drive a competent photocatalytic dye degradation pathway. The heterocyclic base pyridine exclusively develops cocoons. Thus, the mechanism of self‐aggregation of ZnO nanocrystals under MHT reaction conditions has been studied and the characterization of the compounds has been supported with physical measurements.     

Double-CO3(2-) centered [Co(II)5] wheel and modeling of its magnetic properties

A high-spin Co(II) cluster with a rare pentagonal molecular structure and formula [Co(5)(CO(3))(2)(bpp)(5)]ClO(4) (1; Hbpp is 2,6-bis(phenyliminomethyl)-4-methylphenolate) has been synthesized and characterized by single-crystal X-ray diffraction. This topology arises from fusing five [Co(2)(bpp)] moieties in a cyclic manner around two CO(3)(2-) central ligands, resulting in propeller-like configuration. The irregular coordination of the carbonate ions to the metal centers results in a combination of coordination numbers (CNs) of the Co(II) ions of five and six. The bulk magnetization of this complicated magnetically exchanged system has been modeled successfully by employing a matrix diagonalization technique. For this, the combination of S=3/2 ions (CN=5) with ions exhibiting strong spin-orbit coupling (CN=6) has been considered and a perturbative approach to handle the data in the whole studied range of temperatures (2-300 K) yielding parameters of g and D (for the five-coordinate Co(II) ions), of A, κ, λ, and Δ (for the metals with spin-orbit coupling) and of the exchange constants J. The agreement with results from DFT calculations, also presented here, is remarkable.     

Monoclinic CuO nanoflowers on resin support: recyclable catalyst to obtain perylene compound

Monoclinic CuO crystallite in grams has been obtained from resin bound Cu(II)-1,10-phenanthroline complex, R(-)[Cu(1,10-phen)(2)](2+) that becomes a recyclable catalyst for oxidative phenol coupling (OPC) reaction. Thus an exclusively intuitive blue fluorescing perylene derivative is derived from colorless 2,7-dihydroxynaphthalene (2,7-DHN) in high yield.     

Development and validation of an LC-ESI-MS/MS method for simultaneous quantitation of olmesartan and pioglitazone in rat plasma and its pharmacokinetic application

A simple, high‐throughput and specific high‐performance liquid chromatography tandem mass spectrometry method has been developed and validated according to the FDA guidelines for simultaneous quantification of olmesartan and pioglitazone in rat plasma. The bioanalytical method consists of liquid–liquid extraction and quantitation by triple quadrupole mass spectrometry using electrospray ionization technique, operating in multiple reaction monitoring and positive ion modes. The compounds were eluted isocratically on a C₁₈ column with a mobile phase consisting of a mixture of methanol and water (containing 0.5% formic acid) in a ratio of 9:1. The response to olmesartan and pioglitazone was linear over the range 0.01–10 µg/mL. The validation results demonstrated that the method had satisfactory precision and accuracy across the calibration range. Intra‐ and inter‐day precisions ranged from 0.66 to 3.32 and from 0.94 to 2.93% (%CV), respectively. The accuracy determined at three quality control levels was within 91.27–107.28%. There was no evidence of instability of the analytes in rat plasma following the stability studies. The method proved highly reproducible and sensitive and was successfully applied in a pharmacokinetic study after single dose oral administration of olmesartan and pioglitazone to the rat. Copyright © 2010 John Wiley & Sons, Ltd.     

Nanoscale MnII‐Coordination Polymers for Cell Imaging and Heterogeneous Catalysis

A mixed ligand approach was exploited to synthesize a new series of Mn^II‐based coordination polymers (CPs), namely, CP1 {[Mn(μ‐dpa)(μ‐4,4′‐bp)]?MeOH}_∞, CP2 {[Mn₃(μ‐dpa)₃(2,2′‐bp)₂]}_∞, CP3 {[Mn₃(μ‐dpa)₃(1,10‐phen)₂]?2 H₂O}_∞, CP4 {[Mn(μ‐dpa)(μ‐4,4′‐bpe)_1.5]?H₂O}_∞, CP5 {[Mn₂(μ‐dpa)₂(μ‐4,4′‐bpe)₂]? DEF}_∞, and CP6 {[Mn(μ‐dpa)(μ‐4,4′‐bpe)_1.5]? DMA}_∞ (dpa=3,5‐dicarboxyphenyl azide, 2,2′‐bp=2,2′‐bipyridine, 1,10‐phen=1,10‐phenanthroline, 4,4′‐bpe=1,2‐bis(4‐pyridyl)ethylene, 4,4′‐bp=4,4′‐bipyridine, DEF=N,N‐diethylformamide, DMA=N,N‐dimethylacetamide), to develop multifunctional CPs. Various techniques, such as single‐crystal X‐ray diffraction (SXRD), FTIR spectroscopy, elemental analysis, and thermogravimetric analysis, were employed to fully characterize these CPs. The majority of the CPs displayed a four‐connected sql topology, whereas CP4 and CP6 exhibited a two‐dimensional SnS network architecture, which was further entangled in a polycatenation mode. Compound CP1 displayed an open framework structure. The CPs were scaled down to the nanoregime in a ball mill for cell imaging studies. Whereas CP2 and CP4 were employed for cell imaging with RAW264.7 cells, CP1 was exploited for both cell imaging and heterogeneous catalysis in a cyanosilylation reaction.     

Probing mixed valence in a new tppz-bridged diruthenium(III,II) complex {(mu-tppz)[Ru(bik)Cl]2}3+ (tppz=2,3,5,6-tetrakis(2-pyridyl)pyrazine, bik=2,2'-bis(1-methylimidazolyl)ketone): EPR silence, intervalence absorption, and nu(CO) line broadening

The complex dication of the diruthenium(II) compound {(mu-tppz)[Ru(bik)Cl]2}(ClO4)2 can be oxidized and reduced in two one-electron steps each. In CH3CN/0.1 M Bu4NPF6, the odd-electron intermediates{(mu-tppz)[Ru(bik)Cl]2}n+, n=1 and 3, have comproportionation constants of 7x10(8) and 1x10(5), respectively. Both exhibit near-infrared absorptions, in the case of n=3 the 1640 nm band (epsilon=1200 M-1 cm-1, Deltanu1/2=1560 cm-1) is attributed to an intervalence charge-transfer transition. While the mixed-valent intermediate (n=3) is EPR silent even at 4 K, the n=1 form shows g(parallel) 2.005 and g( perpendicular) 1.994 at that temperature, signifying a diruthenium(II) complex of the tppz*- radical anion. The variation of energy and intensity of nuCO and of the ring vibration band around 1590 cm-1 has been monitored not only for {(mu-tppz)[Ru(bik)Cl]2}n+, n=0-4, but also for the mononuclear {(tppz)Ru(bik)Cl}n+, n=0-2. In the dinuclear complex the carbonyl stretching bands of the spectator ligand bik are shifted by about 15 cm-1 on each one-electron-transfer step, increasing with the positive charge. The mixed-valent {(mu-tppz)[Ru(bik)Cl]2}3+ shows a perceptibly broader nuCO band, suggesting incomplete valence averaging (partial localization).     

Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry

Two fast and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS)-based bioanalytical assays were developed and validated to quantify the active and three inactive metabolites of prasugrel. Prasugrel is a novel thienopyridine prodrug that is metabolized to the pharmacologically active metabolite in addition to three inactive metabolites, which directly relate to the formation and elimination of the active metabolite. After extraction and separation, the analytes were detected and quantified using a triple quadrupole mass spectrometer using positive electrospray ionization. The validated concentration range for the inactive metabolites assay was from 1 to 500 ng/mL for each of the three analytes. Additionally, a 5x dilution factor was validated. The interday accuracy ranged from -10.5% to 12.5% and the precision ranged from 2.4% to 6.6% for all three analytes. All results showed accuracy and precision within +/-20% at the lower limit of quantification and +/-15% at other levels. The validated concentration range for the active metabolite assay was from 0.5 to 250 ng/mL. Additionally, a 10x dilution factor was validated. The interbatch accuracy ranged from -7.00% to 5.98%, while the precision ranged from 0.98% to 3.39%. Derivatization of the active metabolite in blood with 2-bromo-3'-methoxyacetophenone immediately after collection was essential to ensure the stability of the metabolite during sample processing and storage. These methods have been applied to determine the concentrations of the active and inactive metabolites of prasugrel in human plasma.